BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rutherford BR, Sneed JR, Tandler JM, Rindskopf D, Peterson BS, Roose SP. Deconstructing pediatric depression trials: an analysis of the effects of expectancy and therapeutic contact. J Am Acad Child Adolesc Psychiatry. 2011;50:782-795. [PMID: 21784298 DOI: 10.1016/j.jaac.2011.04.004] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Rutherford BR, Cooper TM, Persaud A, Brown PJ, Sneed JR, Roose SP. Less is more in antidepressant clinical trials: a meta-analysis of the effect of visit frequency on treatment response and dropout. J Clin Psychiatry 2013;74:703-15. [PMID: 23945448 DOI: 10.4088/JCP.12r08267] [Cited by in Crossref: 29] [Cited by in F6Publishing: 9] [Article Influence: 3.6] [Reference Citation Analysis]
2 Enck P, Klosterhalfen S. Placebo Responses and Placebo Effects in Functional Gastrointestinal Disorders. Front Psychiatry 2020;11:797. [PMID: 33192627 DOI: 10.3389/fpsyt.2020.00797] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Locher C, Koechlin H, Zion SR, Werner C, Pine DS, Kirsch I, Kessler RC, Kossowsky J. Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, and Placebo for Common Psychiatric Disorders Among Children and Adolescents: A Systematic Review and Meta-analysis. JAMA Psychiatry 2017;74:1011-20. [PMID: 28854296 DOI: 10.1001/jamapsychiatry.2017.2432] [Cited by in Crossref: 138] [Cited by in F6Publishing: 90] [Article Influence: 34.5] [Reference Citation Analysis]
4 Weimer K, Colloca L, Enck P. Age and sex as moderators of the placebo response – an evaluation of systematic reviews and meta-analyses across medicine. Gerontology 2015;61:97-108. [PMID: 25427869 DOI: 10.1159/000365248] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 7.8] [Reference Citation Analysis]
5 Eapen V, Črnčec R. Strategies and challenges in the management of adolescent depression: . Current Opinion in Psychiatry 2012;25:7-13. [DOI: 10.1097/yco.0b013e32834de3bd] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
6 Enck P, Klosterhalfen S. Placebos and the Placebo Effect in Drug Trials. In: Barrett JE, Page CP, Michel MC, editors. Concepts and Principles of Pharmacology. Cham: Springer International Publishing; 2019. pp. 399-431. [DOI: 10.1007/164_2019_269] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
7 Enck P, Klosterhalfen S, Weimer K. Unsolved, Forgotten, and Ignored Features of the Placebo Response in Medicine. Clinical Therapeutics 2017;39:458-68. [DOI: 10.1016/j.clinthera.2016.11.016] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
8 Weimer K, Colloca L, Enck P. Placebo eff ects in psychiatry: mediators and moderators. Lancet Psychiatry 2015;2:246-57. [PMID: 25815249 DOI: 10.1016/S2215-0366(14)00092-3] [Cited by in Crossref: 113] [Cited by in F6Publishing: 34] [Article Influence: 28.3] [Reference Citation Analysis]
9 Rutherford BR, Tandler J, Brown PJ, Sneed JR, Roose SP. Clinic visits in late-life depression trials: effects on signal detection and therapeutic outcome. Am J Geriatr Psychiatry 2014;22:1452-61. [PMID: 24200597 DOI: 10.1016/j.jagp.2013.09.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
10 Czerniak E, Oberlander TF, Weimer K, Kossowsky J, Enck P. "Placebo by Proxy" and "Nocebo by Proxy" in Children: A Review of Parents' Role in Treatment Outcomes. Front Psychiatry 2020;11:169. [PMID: 32218746 DOI: 10.3389/fpsyt.2020.00169] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Elsenbruch S, Enck P. Placebo effects and their determinants in gastrointestinal disorders. Nat Rev Gastroenterol Hepatol 2015;12:472-85. [DOI: 10.1038/nrgastro.2015.117] [Cited by in Crossref: 87] [Cited by in F6Publishing: 66] [Article Influence: 14.5] [Reference Citation Analysis]
12 Rutherford BR, Pott E, Tandler JM, Wall MM, Roose SP, Lieberman JA. Placebo response in antipsychotic clinical trials: a meta-analysis. JAMA Psychiatry 2014;71:1409-21. [PMID: 25321611 DOI: 10.1001/jamapsychiatry.2014.1319] [Cited by in Crossref: 74] [Cited by in F6Publishing: 53] [Article Influence: 12.3] [Reference Citation Analysis]
13 Allegaert K. Clinical pharmacological studies in children: From exploratory towards confirmation driven methodology. World J Clin Pediatr. 2012;1:3-7. [PMID: 25254160 DOI: 10.5409/wjcp.v1.i2.3] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
14 Safer DJ, Zito JM. Short- and Long-Term Antidepressant Clinical Trials for Major Depressive Disorder in Youth: Findings and Concerns. Front Psychiatry 2019;10:705. [PMID: 31681028 DOI: 10.3389/fpsyt.2019.00705] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
15 Vitiello B, Ordóñez AE. Pharmacological treatment of children and adolescents with depression. Expert Opin Pharmacother 2016;17:2273-9. [PMID: 27690663 DOI: 10.1080/14656566.2016.1244530] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
16 Rutherford BR, Sneed JR, Roose SP. Does differential drop-out explain the influence of study design on antidepressant response? A meta-analysis. J Affect Disord 2012;140:57-65. [PMID: 22387053 DOI: 10.1016/j.jad.2012.01.031] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
17 Benarous X, Consoli A, Guilé JM, Garny de La Rivière S, Cohen D, Olliac B. Evidence-based treatments for youths with severely dysregulated mood: a qualitative systematic review of trials for SMD and DMDD. Eur Child Adolesc Psychiatry 2017;26:5-23. [PMID: 27662894 DOI: 10.1007/s00787-016-0907-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
18 Fountoulakis KN, McIntyre RS, Carvalho AF. From Randomized Controlled Trials of Antidepressant Drugs to the Meta-Analytic Synthesis of Evidence: Methodological Aspects Lead to Discrepant Findings. Curr Neuropharmacol 2015;13:605-15. [PMID: 26467410 DOI: 10.2174/1570159x13666150630174343] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
19 Enck P, Zipfel S. Placebo Effects in Psychotherapy: A Framework. Front Psychiatry 2019;10:456. [PMID: 31293462 DOI: 10.3389/fpsyt.2019.00456] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 9.5] [Reference Citation Analysis]
20 Weimer K, Gulewitsch MD, Schlarb AA, Schwille-Kiuntke J, Klosterhalfen S, Enck P. Placebo effects in children: a review. Pediatr Res 2013;74:96-102. [PMID: 23598811 DOI: 10.1038/pr.2013.66] [Cited by in Crossref: 107] [Cited by in F6Publishing: 68] [Article Influence: 13.4] [Reference Citation Analysis]
21 Rutherford BR, Roose SP. A model of placebo response in antidepressant clinical trials. Am J Psychiatry 2013;170:723-33. [PMID: 23318413 DOI: 10.1176/appi.ajp.2012.12040474] [Cited by in Crossref: 145] [Cited by in F6Publishing: 110] [Article Influence: 18.1] [Reference Citation Analysis]
22 Youssef EA, Berry-Kravis E, Czech C, Hagerman RJ, Hessl D, Wong CY, Rabbia M, Deptula D, John A, Kinch R, Drewitt P, Lindemann L, Marcinowski M, Langland R, Horn C, Fontoura P, Santarelli L, Quiroz JA; FragXis Study Group. Effect of the mGluR5-NAM Basimglurant on Behavior in Adolescents and Adults with Fragile X Syndrome in a Randomized, Double-Blind, Placebo-Controlled Trial: FragXis Phase 2 Results. Neuropsychopharmacology 2018;43:503-12. [PMID: 28816242 DOI: 10.1038/npp.2017.177] [Cited by in Crossref: 63] [Cited by in F6Publishing: 43] [Article Influence: 15.8] [Reference Citation Analysis]
23 Wang SM, Han C, Lee SJ, Jun TY, Patkar AA, Masand PS, Pae CU. Efficacy of antidepressants: bias in randomized clinical trials and related issues. Expert Rev Clin Pharmacol 2018;11:15-25. [PMID: 28893095 DOI: 10.1080/17512433.2017.1377070] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
24 Rutherford BR, Bailey VS, Schneier FR, Pott E, Brown PJ, Roose SP. INFLUENCE OF STUDY DESIGN ON TREATMENT RESPONSE IN ANXIETY DISORDER CLINICAL TRIALS. Depress Anxiety 2015;32:944-57. [PMID: 26437267 DOI: 10.1002/da.22433] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
25 Motter JN, Devanand DP, Doraiswamy PM, Sneed JR. Clinical Trials to Gain FDA Approval for Computerized Cognitive Training: What Is the Ideal Control Condition? Front Aging Neurosci 2016;8:249. [PMID: 27853432 DOI: 10.3389/fnagi.2016.00249] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.2] [Reference Citation Analysis]
26 Koechlin H, Kossowsky J, Gaab J, Locher C. How to address the placebo response in the prescription SSRIs and SNRIs in children and adolescents. Expert Opin Drug Saf 2018;17:537-40. [PMID: 29781324 DOI: 10.1080/14740338.2018.1475558] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Rutherford BR, Marcus SM, Wang P, Sneed JR, Pelton G, Devanand D, Duan N, Roose SP. A randomized, prospective pilot study of patient expectancy and antidepressant outcome. Psychol Med 2013;43:975-82. [PMID: 22971472 DOI: 10.1017/S0033291712001882] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
28 Zilcha-Mano S, Roose SP, Brown PJ, Rutherford BR. A Machine Learning Approach to Identifying Placebo Responders in Late-Life Depression Trials. Am J Geriatr Psychiatry 2018;26:669-77. [PMID: 29398354 DOI: 10.1016/j.jagp.2018.01.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 6.3] [Reference Citation Analysis]
29 Roose SP, Rutherford BR, Wall MM, Thase ME. Practising evidence-based medicine in an era of high placebo response: number needed to treat reconsidered. Br J Psychiatry 2016;208:416-20. [PMID: 27143006 DOI: 10.1192/bjp.bp.115.163261] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
30 Simmons K, Ortiz R, Kossowsky J, Krummenacher P, Grillon C, Pine D, Colloca L. Pain and placebo in pediatrics: a comprehensive review of laboratory and clinical findings. Pain 2014;155:2229-35. [PMID: 25180010 DOI: 10.1016/j.pain.2014.08.036] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
31 Sukhodolsky DG, Woods DW, Piacentini J, Wilhelm S, Peterson AL, Katsovich L, Dziura J, Walkup JT, Scahill L. Moderators and predictors of response to behavior therapy for tics in Tourette syndrome. Neurology. 2017;88:1029-1036. [PMID: 28202705 DOI: 10.1212/wnl.0000000000003710] [Cited by in Crossref: 47] [Cited by in F6Publishing: 14] [Article Influence: 11.8] [Reference Citation Analysis]
32 Dobson ET, Strawn JR. Placebo Response in Pediatric Anxiety Disorders: Implications for Clinical Trial Design and Interpretation. J Child Adolesc Psychopharmacol 2016;26:686-93. [PMID: 27027330 DOI: 10.1089/cap.2015.0192] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
33 Weimer K, Enck P. Traditional and Innovative Experimental and Clinical Trial Designs and Their Advantages and Pitfalls. In: Benedetti F, Enck P, Frisaldi E, Schedlowski M, editors. Placebo. Berlin: Springer Berlin Heidelberg; 2014. pp. 237-72. [DOI: 10.1007/978-3-662-44519-8_14] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]